retatrutide fda approval 2026 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation What To Know About Buying

Gastroprotection should be considered in these higher-risk scenarios according to NICE Clinical Knowledge Summaries guidance

If using the upper arm, a caregiver should administer the dose

If you live in Brooklyn or the surrounding area, now may be a good time to consider whether GLP-1 therapy could be appropriate

This combination is common in diabetes management, and the increased urination is an expected, intended therapeutic effect

Mir Ali, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, told Medical News Today : As these medications increase in use and popularity, we will likely see more effects as people achieve their weight loss goals